Bone Markers Status in Graves’ disease before and after Treatment
"nBackground:  Bone turnover is reported to increase in favor of resorption in overt hyperthyroidism and the rate of resorp­tion is associated with the levels of thyroid hormones. As persistent increase in bone turn over is responsible for accelerated bone loss, pat...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2008-11-01
|
| Series: | Iranian Journal of Public Health |
| Subjects: | |
| Online Access: | http://localhost/ep/PdfMed.aspx?pdf_med=/upload_files/pdf/12887.pdf&manuscript_id=12887 |
| _version_ | 1818906120658354176 |
|---|---|
| author | P Tofighi P Shoushtarizadeh A Hossein-nezhad V Haghpanah B Rajabi-pour Kh Adabi S Sharghi B Larijani |
| author_facet | P Tofighi P Shoushtarizadeh A Hossein-nezhad V Haghpanah B Rajabi-pour Kh Adabi S Sharghi B Larijani |
| author_sort | P Tofighi |
| collection | DOAJ |
| description | "nBackground:  Bone turnover is reported to increase in favor of resorption in overt hyperthyroidism and the rate of resorp­tion is associated with the levels of thyroid hormones. As persistent increase in bone turn over is responsible for accelerated bone loss, patients with Graves' disease may have increased risk for osteoporosis. The aim of this study was to determine relationship between Graves' disease and bone markers."nMethods: The subjects of our study were 31 consecutive untreated GD patients and 37 normal volunteers who were matched on sex proportion and age ranging was diagnosed by suppressed levels of TSH and elevated level of free T3 and free T4 and positive thyroid receptor antibody. Through a clinical trial study executed in endocrinology and metabolism research center, we investigated the relationship between serum osteocalcin & cross-laps with Graves' disease and then kinds of treatment with PTU and methimazole after 8 weeks follow up."nResults: No significant differences in age and sex between patients and controls were found. Significant differences in se­rum bone markers and thyroid hormones were detected between patients and controls before therapy (p< 0.001). After treatment we found a significant improvement and returning to normal range in all serum lab tests. There were not any dif­ferences in the effect of treatment on thyroid hormones and bone markers between two groups."nConclusion: We found close relationship between Graves' disease and bone markers. So that treatment of Graves' disease can improve bone turn over. These findings indicated that early diagnosis and management of Graves' disease can be effec­tive for osteoporosis prevention in these patients. |
| first_indexed | 2024-12-19T21:34:11Z |
| format | Article |
| id | doaj.art-7b15b109b16748428cbb075870fb46c3 |
| institution | Directory Open Access Journal |
| issn | 2251-6085 |
| language | English |
| last_indexed | 2024-12-19T21:34:11Z |
| publishDate | 2008-11-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | Iranian Journal of Public Health |
| spelling | doaj.art-7b15b109b16748428cbb075870fb46c32022-12-21T20:04:50ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852008-11-01371 sup3035Bone Markers Status in Graves’ disease before and after TreatmentP TofighiP ShoushtarizadehA Hossein-nezhadV HaghpanahB Rajabi-pourKh AdabiS SharghiB Larijani"nBackground:  Bone turnover is reported to increase in favor of resorption in overt hyperthyroidism and the rate of resorp­tion is associated with the levels of thyroid hormones. As persistent increase in bone turn over is responsible for accelerated bone loss, patients with Graves' disease may have increased risk for osteoporosis. The aim of this study was to determine relationship between Graves' disease and bone markers."nMethods: The subjects of our study were 31 consecutive untreated GD patients and 37 normal volunteers who were matched on sex proportion and age ranging was diagnosed by suppressed levels of TSH and elevated level of free T3 and free T4 and positive thyroid receptor antibody. Through a clinical trial study executed in endocrinology and metabolism research center, we investigated the relationship between serum osteocalcin & cross-laps with Graves' disease and then kinds of treatment with PTU and methimazole after 8 weeks follow up."nResults: No significant differences in age and sex between patients and controls were found. Significant differences in se­rum bone markers and thyroid hormones were detected between patients and controls before therapy (p< 0.001). After treatment we found a significant improvement and returning to normal range in all serum lab tests. There were not any dif­ferences in the effect of treatment on thyroid hormones and bone markers between two groups."nConclusion: We found close relationship between Graves' disease and bone markers. So that treatment of Graves' disease can improve bone turn over. These findings indicated that early diagnosis and management of Graves' disease can be effec­tive for osteoporosis prevention in these patients.http://localhost/ep/PdfMed.aspx?pdf_med=/upload_files/pdf/12887.pdf&manuscript_id=12887 Graves' diseaseBone TurnoverHyperthyroidismOsteoporosis |
| spellingShingle | P Tofighi P Shoushtarizadeh A Hossein-nezhad V Haghpanah B Rajabi-pour Kh Adabi S Sharghi B Larijani Bone Markers Status in Graves’ disease before and after Treatment Iranian Journal of Public Health Graves' disease Bone Turnover Hyperthyroidism Osteoporosis |
| title | Bone Markers Status in Graves’ disease before and after Treatment |
| title_full | Bone Markers Status in Graves’ disease before and after Treatment |
| title_fullStr | Bone Markers Status in Graves’ disease before and after Treatment |
| title_full_unstemmed | Bone Markers Status in Graves’ disease before and after Treatment |
| title_short | Bone Markers Status in Graves’ disease before and after Treatment |
| title_sort | bone markers status in graves disease before and after treatment |
| topic | Graves' disease Bone Turnover Hyperthyroidism Osteoporosis |
| url | http://localhost/ep/PdfMed.aspx?pdf_med=/upload_files/pdf/12887.pdf&manuscript_id=12887 |
| work_keys_str_mv | AT ptofighi bonemarkersstatusingravesdiseasebeforeandaftertreatment AT pshoushtarizadeh bonemarkersstatusingravesdiseasebeforeandaftertreatment AT ahosseinnezhad bonemarkersstatusingravesdiseasebeforeandaftertreatment AT vhaghpanah bonemarkersstatusingravesdiseasebeforeandaftertreatment AT brajabipour bonemarkersstatusingravesdiseasebeforeandaftertreatment AT khadabi bonemarkersstatusingravesdiseasebeforeandaftertreatment AT ssharghi bonemarkersstatusingravesdiseasebeforeandaftertreatment AT blarijani bonemarkersstatusingravesdiseasebeforeandaftertreatment |